“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”
Document Type
News Article
Publication Date
8-1-2023
Keywords
washington; spokane; prmc
Clinical Institute
Kidney & Diabetes
Specialty
Endocrinology
Specialty
Nephrology
Recommended Citation
Tuttle, Katherine, "“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”" (2023). Articles, Abstracts, and Reports. 8247.
https://digitalcommons.providence.org/publications/8247
Comments
Pharmacy Times